Home / Nervous system / Brivaracetam
ATC N03AX23 · Other Antiepileptics
Brivaracetam shortage
As of 2 Nov 2026, Brivaracetam has a reported shortage in 1 of the 15 countries we track (Canada), covering 1 product from 1 company.
Countries1/15
Products1packs or presentations
Companies10 listed
Short since13 Oct 202620 days ago
Earliest return4 Dec 2026company estimate
Main reasonManufacturing problem
United StatesNo reported shortageCanada1 product shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapanNo reported shortageAustraliaNo reported shortage
Timeline
Canada
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesCompared with similar medicines
ATC group N03AX · Other AntiepilepticsAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | APO-BRIVARACETAM (60 BTL) | APOTEX INC | 13 Oct 2026 | 4 Dec 2026 | Manufacturing problem Disruption of the manufacture of the drug |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.